Apellis Pharmaceuticals

Youtube Subscribe

Open: 63.98 Close: 63.8 Change: -0.18

11 lessons that an AI found about Apellis Pharmaceuticals Company Inc Stock after reading internet.

Are looking for the most relevant information about Apellis Pharmaceuticals? Investor spend a lot of time searching for information to make investment decisions in Apellis Pharmaceuticals. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Apellis Pharmaceuticals are: Apellis, Pharmaceuticals, rating, price, Inc, share, Sells, and the most common words in the summary are: pharmaceutical, apellis, stock, job, inc, price, share, . One of the sentences in the summary was: Analysts have a conensus rating of Moderate Buy which is based …

Concept Map

Semantic Network

Stock Summary

Apellis Pharmaceuticals Inc. (APLS) price may drop as it broke higher Bollinger Band on Oct 13, 2023. The company has a Bullish sentiment reading. Wall Street Analysts Think 67.65% Wall.

Today's Summary

Analysts have a conensus rating of Moderate Buy which is based on 11 buy ratings, 4 hold ratings and 0 sell ratings. Apellis Pharmaceuticals Inc has 13.21% upside potential, based on the analysts average price target of $72.23.

Today's News

Apellis Pharmaceuticals Inc. Chief Medical Officer Caroline Baumal Sells 2,751 Shares Jan. ET on GuruFocus.com CEO sells shares. Apellis Pharmaceuticals Inc has 13.21% upside potential, based on the analysts average price target of $72.23. Analysts have a conensus rating of Moderate Buy which is based on 11 buy ratings, 4 hold ratings and 0 sell ratings. Apellis Pharmaceuticals -0.13% Today Market Cap Cap $7.56M (1.82M) Low Volume (52-WKW) Low Volatility (WV) HC Wainwright Boosts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $92.00 Zolmax. CEO Jeffrey Eisele Sells 438 Shares Ticker Report. Apellis Pharmaceuticals currently has a consensus rating of “Moderate Buy” and an average target price of $72.71. According to MarketBeat.com, the company has a. consensus rating. Apellis Pharmaceuticals (APLS) is in the Health Care sector and Biotechnology industry. Q4 earnings are confirmed for Tuesday, February 20, 2024. There is no dividend information. The closing price of the Apellis Pharmaceuticals Inc Registered Shs share was $63.80 on Thursday 01/18/2024 on NAS. This is a drop of 0.28% compared to the opening price on Thursday. The market capitalization is $7.56 B by 118.50 M shares.

Stock Profile

" Apellis Pharmaceuticals Inc. (APLS) stock has risen 9% while the S&P 500 has fallen -0.6% as of 1:14 PM on Friday, Oct 13. The company has a Bullish sentiment reading. Wall Street Analysts Think 67.65% The mean of analysts price targets for Apellis Pharmaceuticals, Inc. (apls) stock price, news, quote & history - yahoo finance.com Insider Sell: Pascal Deschatelets Sells 12,000 Shares. Apellis Pharmaceuticals Inc (APLS) price may drop as it broke higher Bollinger Band on Oct 13, 2023. This price move could be a signal that APLS may fall back below the higher band. Apellis Pharmaceuticals, Inc. (APLS) Investors have opportunity to lead a class action lawsuit against the Company. Apellis Pharmaceuticals traded as high as $50.49 and last traded at $49.47. The company has a market cap of $5.70 billion, a price-to-earnings ratio of -8.31. Hedge funds and other institutional investors have recently added to or reduced their stakes in APLS. Apellis Pharmaceuticals stock (NASDAQ: APLS) stock price, news, charts, stock research, profile. Daily Ratings & News for Apelli Pharmaceuticals. Complete the form below to receive the latest headlines."

Keywords

This document will help you to evaluate Apellis Pharmaceuticals without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Apellis Pharmaceuticals are: Apellis, Pharmaceuticals, rating, price, Inc, share, Sells, and the most common words in the summary are: pharmaceutical, apellis, stock, job, inc, price, share, . One of the sentences in the summary was: Analysts have a conensus rating of Moderate Buy which is based on 11 buy ratings, 4 hold ratings and 0 sell ratings. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pharmaceutical #apellis #stock #job #inc #price #share.

Read more →

Youtube Subscribe

---